Back
Sarepta Therapeutics Stock Predictions
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$73.40
Seasonality Move:
14.66%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Sarepta Therapeutics Stock Forecast
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.3% based on the past 27 years of stock performance.
-
Sarepta Therapeutics has risen higher in 14 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.85%
-
Is Sarepta Therapeutics Stock Undervalued?The current Sarepta Therapeutics [SRPT] share price is $79.97. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.3% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
-
Sarepta Therapeutics has risen higher in 14 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.85%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
73.06
Prediction Charts
Market Cap:
7.8B
Price in USD:
79.97
Volume:
5M
Beta:
1.05
Technical Analysis
SMA50:
110.69
SMA100:
116.66
SMA200:
125.58
52-Wk Change:
-35.54%
Stock Predictions
-
Is Sarepta Therapeutics stock public?Yes, Sarepta Therapeutics is a publicly traded company.
-
What is the Sarepta Therapeutics stock quote today?The Sarepta Therapeutics stock price is 79.97 USD today.
-
How to buy Sarepta Therapeutics stock online?You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-27 | 101.00 | 103.12 | 109.50 | 101.00 |
| Feb-28 | 104.21 | 106.89 | 108.48 | 103.46 |
| Mar-3 | 106.75 | 101.24 | 107.35 | 100.15 |
| Mar-4 | 100.25 | 102.88 | 103.59 | 99.50 |
| Mar-5 | 102.94 | 107.72 | 107.77 | 102.94 |
| Mar-6 | 106.79 | 105.65 | 107.23 | 104.39 |
| Mar-7 | 104.02 | 103.03 | 104.85 | 102.00 |
| Mar-11 | 99.16 | 100.71 | 101.56 | 97.91 |
| Mar-12 | 101.72 | 99.77 | 102.40 | 99.02 |
| Mar-13 | 99.65 | 98.37 | 100.01 | 97.11 |
| Mar-14 | 99.00 | 97.19 | 100.00 | 97.06 |
| Mar-17 | 97.35 | 101.35 | 103.32 | 97.35 |
| Mar-18 | 78.62 | 73.54 | 81.87 | 73.06 |
| Mar-19 | 75.18 | 79.97 | 80.98 | 75.13 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.